Generics ; India Scores Over China

When it comes to generic drug market in US, Indian companies show the way. They are consistently ahead of China in number of ANDAs amd DMFs.

Business Line has an article. India scores over China in US generic drug market

India’s DMF filings in the US increased from 187 in 2004 to 252 in 2005 to 357 in 2006. Comparatively, China’s DMF filings in the US increased from 48 in 2004 to 87 in 2005 to 128 in 2006

One in four abbreviated new drug applications (ANDA), filed to be able to sell the medicine in the US, is from an Indian drug company.